Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Nov 8;9:295. doi: 10.1186/s13287-018-1037-4

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 5 — Scatter plots from mixed lymphocyte reactions measuring MSC immunomodulatory capacity shown as percent change in mean fluorescence intensity (MFI) compared to TNCC in each group a-c after the naive injection and d-f after the primed injection. Unstimulated responder lymphocytes were used to calculate percent change. There were no significant correlations in the AUTO or ALLO group at either time points (day 1: AUTO p = 0.40, ALLO p = 0.36; day 30: AUTO p = 0.46, ALLO p = 0.49). A significant correlation was noted in the FBS group after both injections (day 1, p = 0.04; day 30, p = 0.04)